Clinical Trial Update: Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis. [NA]

View source ↗

Summary

Clinical trial evaluating whether lidocaine reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients undergoing ERCP. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche | Conditions: ERCP Surgery | NA | Status: RECRUITING